Enhancer-gene mapping with SCENT method offers insights into disease mechanisms

Genetic studies of diseases map segments of the genome driving disease. But to understand how those changes contribute to disease progression, it is important to understand how they may alter gene regulation of disease genes in cell populations assumed to be driving disease.

Q3 2024 update: artificial intelligence related private equity activity in the pharmaceutical industry

In value terms, artificial intelligence-related deal activity increased by 50% in Q3 2024 compared with the previous quarter’s total of $2.8m and fell by 100%

November 8, 2024

Roche heads to FDA with Gazyva results in a form of lupus

Almost 16 years after Rituxan’s disappointing data in lupus, Roche’s Genentech found success with a different B cell-killing drug called Gazyva in lupus nephritis …

February 8, 2025

Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023 – Psychedelic Alpha

VANCOUVER, BC, July 10, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF) – a mental health care company advancing innovative

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.